Reaction
Erythema Dyschromicum Perstans reporting signals
As of the last recalculation, Erythema Dyschromicum Perstans appears in 53 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ERLOTINIB (PRR 1,409.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Erlotinib | 21 | 1,409.3 | 1,412.4 |
| Erlotinib Hydrochloride | 21 | 1,090.9 | 1,092.7 |
| Osimertinib | 8 | 115.3 | 115.3 |